- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01495078
Telemonitoring and Teleintervention of Heart Failure and Decrease of Non-fatal Events. (ICOR)
Study Overview
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Barcelona, Spain, 08003
- Parc de Salut Mar
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients discharged from a heart failure hospitalization within 30 days of enrollment into the study.
Exclusion Criteria:
- Less than 18 years
- Long-term nursing home residence, irreversible medical conditions, Folstein Mini-mental State Exam score less than 20.
- No access to 3G line, currently scheduled for cardiac transplant, left ventricular assist device or valvular surgery,coronary intervention within 90 days of randomisation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Telemonitoring
Patients with follow-up telemonitoring
|
Is a computer system designed jointly by engineers and clinical personal of Parc Salut Mar) to be able daily automated selfreported symptom and weight, blood pressure and heart rate monitoring . The system allow weekly follow up throught videoconferences. Information from the telemonitoring system is automatically downloaded to a secure Internet site for review by clinicians and nurses. |
NO_INTERVENTION: Non - telemonitoring
Patients with usual face follow-up
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Non fatal events
Time Frame: Six months after inclusion of the patient.
|
Non fatal events are defined as an event of descompensation requiring either parenteral treatment as outpatients in a day hospital an in the emergency department or by income.
|
Six months after inclusion of the patient.
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Morbid mortality
Time Frame: From telemonitoring (baseline) until six months later
|
From telemonitoring (baseline) until six months later
|
Hospital readmission
Time Frame: From telemonitoring (baseline) until six months later
|
From telemonitoring (baseline) until six months later
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: JOSEP COMIN COLET, MD, Hospital del Mar Medical Research Institute
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Proyecto ICOR
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure
-
Tufts Medical CenterMetro West Medical CenterCompletedCongestive Heart Failure | Diastolic Heart Failure | Systolic Heart FailureUnited States
-
Abbott Medical DevicesCompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...United States, Canada
-
Manipal UniversityUnknownHeart Failure | Decompensated Heart Failure | Acute Heart Failure | Diastolic Heart Failure | Systolic Heart FailureIndia
-
University Hospital, MontpellierCompletedHeart Failure | Diastolic Heart Failure | Systolic Heart Failure Stage CFrance
-
VA Eastern Colorado Health Care SystemNational Institute on Aging (NIA)CompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure AcuteUnited States
-
Wake Forest UniversityCompletedHeart Failure, Congestive | Heart Failure With Preserved Ejection Fraction
-
Giresun UniversityIstanbul University - Cerrahpasa (IUC)RecruitingHeart Failure | Diastolic Heart Failure | Systolic Heart FailureTurkey
-
Lancaster General HospitalLouise von Hess Medical Research InstituteEnrolling by invitationDiastolic Heart FailureUnited States
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
-
US Department of Veterans AffairsCompleted
Clinical Trials on Telemonitoring
-
Aalborg University HospitalAalborg University; Steno Diabetes Center NordjyllandRecruiting
-
Chang Hee, LeePurdue University; LG Electronics Inc.CompletedHypertensionKorea, Republic of
-
ResMedCompleted
-
Fundació Institut de Recerca de l'Hospital de la...Sociedad Española de Neumología y Cirugía Torácica; Societat Catalana de Pneumologia...RecruitingNon Invasive VentilationSpain
-
Istituto Auxologico ItalianoRecruiting
-
humanITcareUniversity of Barcelona; Hospital Universitario de Torrevieja; European Innovation...RecruitingHeart FailureSpain, Romania
-
Research and Practical Clinical Center for Diagnostics...Sechenov UniversityEnrolling by invitationInflammatory Bowel Diseases | Crohn Disease | Ulcerative ColitisRussian Federation
-
Hospital Universitari de BellvitgeInstitut d'Investigació Biomèdica de BellvitgeCompleted
-
Turku University HospitalUniversity of TurkuTerminated
-
International Society for Vascular HealthUnknown